A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study

2009882 citationsJournal Article

Authors

Good health and well-being

Published in: American Journal of Ophthalmology

Volume 148, Issue 1, pp. 43-58.e1

Field-Weighted Citation Impact: 66.21